Literature DB >> 18798033

Physically cross-linked polyvinyl alcohol for the topical delivery of fluconazole.

Mona M A Abdel-Mottaleb1, N D Mortada, A A El-Shamy, G A S Awad.   

Abstract

The aim of this study was to develop fluconazole in an ultrapure polyvinyl alcohol (PVA) hydrogel able to deliver the drug in a sustained release pattern for local treatment of skin fungal infections. The topical fluconazole hydrogels were prepared using PVA hydrogels physically cross-linked by freeze-thaw technique. Polyethylene glycol (PEG) was added as a hydrophilic excipient as a release enhancer of fluconazole. The effects of PVA molecular weight, PEG molecular weight, and PEG concentration were studied using a 2 x 4 x 2 factorially designed experiment. The selected fluconazole hydrogel proved to be physically stable over a period of 6 months and to be effective in the topical treatment of cutaneous candidiasis. Therefore, it could be concluded that the formula composed of 10% PVA 205000 and 1.5% PEG 4000 and 2% fluconazole and prepared by three cycles of freezing, and thawing is very promising in the local treatment of skin fungal infection as an alternative to the systemic use of fluconazole.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18798033     DOI: 10.1080/03639040802325893

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  9 in total

Review 1.  Designing degradable hydrogels for orthogonal control of cell microenvironments.

Authors:  Prathamesh M Kharkar; Kristi L Kiick; April M Kloxin
Journal:  Chem Soc Rev       Date:  2013-04-22       Impact factor: 54.564

2.  Treatment of cutaneous candidiasis through fluconazole encapsulated cubosomes.

Authors:  Vijay Prajapati; Aakanchha Jain; Richa Jain; Sanjeev Sahu; Dharm Veer Kohli
Journal:  Drug Deliv Transl Res       Date:  2014-12       Impact factor: 4.617

3.  Influence of colloidal silicon dioxide on gel strength, robustness, and adhesive properties of diclofenac gel formulation for topical application.

Authors:  Zheng Lu; Reza Fassihi
Journal:  AAPS PharmSciTech       Date:  2014-12-11       Impact factor: 3.246

4.  The Effect of Particle Size on the Deposition of Solid Lipid Nanoparticles in Different Skin Layers: A Histological Study.

Authors:  Zahra Mardhiah Adib; Saeed Ghanbarzadeh; Maryam Kouhsoltani; Ahmad Yari Khosroshahi; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2016-03-17

5.  Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1).

Authors:  Chris Brough; Dave A Miller; Justin M Keen; Shawn A Kucera; Dieter Lubda; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-12-04       Impact factor: 3.246

6.  Fabrication, characterization, and evaluation of microsponge delivery system for facilitated fungal therapy.

Authors:  Afrasim Moin; Tamal K Deb; Riyaz Ali M Osmani; Rohit R Bhosale; Umme Hani
Journal:  J Basic Clin Pharm       Date:  2016-03

7.  Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study.

Authors:  Shaimaa El-Housiny; Maii Atef Shams Eldeen; Yasmina Ahmed El-Attar; Hoda A Salem; Dalia Attia; Ehab R Bendas; Mohamed A El-Nabarawi
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

8.  Fluconazole conjugated-gold nanorods as an antifungal nanomedicine with low cytotoxicity against human dermal fibroblasts.

Authors:  Khawla M Hamad; Nouf N Mahmoud; Sabaa Al-Dabash; Luma A Al-Samad; Maha Abdallah; Amal G Al-Bakri
Journal:  RSC Adv       Date:  2020-07-08       Impact factor: 4.036

9.  New Approach to Antifungal Activity of Fluconazole Incorporated into the Porous 6-Anhydro-α-l-Galacto-β-d-Galactan Structures Modified with Nanohydroxyapatite for Chronic-Wound Treatments-In Vitro Evaluation.

Authors:  Justyna Rewak-Soroczynska; Paulina Sobierajska; Sara Targonska; Agata Piecuch; Lukasz Grosman; Jaroslaw Rachuna; Slawomir Wasik; Michal Arabski; Rafal Ogorek; Rafal J Wiglusz
Journal:  Int J Mol Sci       Date:  2021-03-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.